Showing results (551-560 of 572) with videos related to

Sort By:
Pageof 58
Trials|January 24, 2016
Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trialKonstantinos Kalafatakis, Georgina M Russell, Catherine J Harmer, et al.
Journal of Psychiatry & Neuroscience : JPN|June 20, 2020
Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humansKelly Smart, Atsuko Nagano-Saito, Michele S Milella, et al.
Journal of Molecular Neuroscience : MN|October 12, 2017
Role of Dynein Axonemal Heavy Chain 6 Gene Expression as a Possible Biomarker for Huntington's Disease: a Translational StudyLorena B Areal, Lorraine P Pereira, Fabiola M Ribeiro, et al.
Palliative Medicine|July 28, 2007
The challenge of patients' unmet palliative care needs in the final stages of chronic illnessD Fitzsimons, D Mullan, J S Wilson, et al.
Nature Neuroscience|November 29, 2005
ORL1 receptor-mediated internalization of N-type calcium channelsChristophe Altier, Houman Khosravani, Rhian M Evans, et al.
The New England Journal of Medicine|November 13, 1998
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial CollaboratorsH J Barnett, D W Taylor, M Eliasziw, et al.
The Journal of Biological Chemistry|December 25, 2000
Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablationY Sato, H Kiriazis, A Yatani, et al.
Journal of Cellular Biochemistry|July 20, 2004
Lysophosphatidic acid production and action: validated targets in cancer?Makiko Umezu-Goto, Janos Tanyi, John Lahad, et al.
Neuron|December 1, 2014
A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effectsPing Su, Shupeng Li, Sheng Chen, et al.
American Heart Journal|October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA StudyJonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.
Pageof 58